Publications by authors named "E N Pivovarova"
Article Synopsis
- - The study explores the challenges faced by community-based providers of medications for opioid use disorders (MOUD) when collaborating with recovery courts, which mandate treatment instead of incarceration but rely on outside resources for support.
- - Providers reported that a lack of knowledge about recovery courts, negative feelings toward the criminal justice system, and staffing shortages hinder effective collaboration, while complex communication requirements and unresponsive courts were common obstacles.
- - Despite these barriers, direct interactions with recovery court staff and shared goals of helping individuals in recovery were identified as key factors that could enhance collaboration and improve access to care.
Objectives: As carceral settings increasingly offer medications for opioid use disorders (MOUD), community-based providers will need to navigate relationships with correctional agencies to ensure continuity of MOUD upon release. Although collaboration has been identified as critical between agencies, limited research is available that details how providers can work with jails. We describe the perspectives of MOUD providers about their experiences collaborating with jails that had recently begun to offer MOUD.
View Article and Find Full Text PDFArticle Synopsis
- Problem-solving courts (PSCs) aim to provide alternatives to traditional prosecution and support for individuals with drug-related issues, particularly those facing challenges with opioid use disorder, but medications like methadone and buprenorphine remain underutilized among PSC clients.
- A study involving semi-structured interviews with 54 PSC staff across four states revealed that most courts have lifted blanket prohibitions on medication for opioid use disorder (MOUD) due to changes in policies and education, but staff preferences and concerns still influence individual client decisions.
- The decision-making factors for allowing MOUD include the type of treatment provider, communication with the court, and adherence to certain criteria, with staff expressing more comfort towards buprenorphine than methadone
Background: Incarceration provides an opportunity for health interventions, including opioid use disorder (OUD) treatment and prevention of opioid-related overdoses post-release. All FDA-approved forms of medication for OUD (MOUD) treatment were mandated in several Massachusetts jails in 2019, with some jails offering extended-release buprenorphine (XR-Bup). Little is known about patient perspectives on and experiences with XR-Bup in carceral settings.
View Article and Find Full Text PDFUsing H NMR spectroscopy, we studied the relative mobility of the NO group in 1-alkyl-5-nitro-1,2,4-triazoles in the reaction of nucleophilic heterocyclic substitution by aliphatic oligoethers. The main pathways of the substitution process and the composition of resultant products from competitive reactions were examined, and the key factors influencing the relative mobility of the nitro group, such as the nitrotriazole substrate constitution, the carbon skeleton length of the -nucleophilic agent and the process conditions, were discussed. Several independent competitive reactions directed towards the substitution of the nitro group at position C(5) in the alkyltriazole substrate by different types of nucleophiles such as alkoxide-, hydroxide- and triazolonate anions were observed to take place under conditions used.
View Article and Find Full Text PDF